应用聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎患者血清sVAP-1和SAA水平变化及其临床意义探讨*
杨凯, 张凯, 汪勇
Implication of serum sVAP-1 and SAA levels in patients with chronic hepatitis C receiving pegylated interferon α-2a and ribavirin standardized treatment
Yang Kai, Zhang Kai, Wang Yong
实用肝脏病杂志
.
2023, (4): 484
-487
.
DOI: 10.3969/j.issn.1672-5069.2023.04.008
